A 'Bear Raid' in Affymax (AFFY)?; Shares Plunge
Tweet
Share
E-mail
Get Alerts AFFY Hot Sheet
Join SI Premium – FREE
Traders are chatting about the "bear raid" being seen in Affymax, Inc. (Nasdaq: AFFY) ahead of today's FDA decision on peginesatide, which in December an FDA panel backed 15 to 1.
Shares of AFFY are recovering off the lows, but still down 8.5%.
Shares of AFFY are recovering off the lows, but still down 8.5%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Buyout firm Vista explores $3B sale of private markets data provider Allvue - Reuters
- Startup Micro1 offering $12.5M for Spirit Airlines data - Business Insider
- D.E. Shaw owns $1B+ stake in Sysco - Reuters
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
